http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200079203-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_846e4126ceec43f5b1b0ae66ee66c01f |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-45 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-45 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-08 |
| filingDate | 2019-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04b5da28e6e9a96aa5a9cd440869554b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6658012952a84081d6fe0f9ed48ef5e |
| publicationDate | 2020-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20200079203-A |
| titleOfInvention | Composition for preventing or treating bon disease comprising extract of blueberry |
| abstract | The present invention relates to a composition for preventing, treating or improving bone diseases such as osteoclast differentiation and osteoporosis including blueberry extract, the present invention is a composition containing blueberry extract has no cytotoxicity, NFATc1 (nuclear factor of activated T cells cytoplasmic 1), suppresses the expression of c-Fos, inhibits the activity of the TRAP enzyme, thereby suppressing the differentiation from monocytes to osteoclasts, and thus can be useful for the prevention, treatment, or improvement of bone diseases including osteoporosis. . |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20220057673-A |
| priorityDate | 2018-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 73.